equityflowunderstand the flow and follow it
EquityFlowCompanies › Setsurotech

Setsurotech

Biotech · Tokushima, JP

Contract genome editing services (CRISPR mice/rats, cells) and precision breeding, a Tokushima University spin-off.

In the network

Shares the most investors with (number = shared investors):

Funding history

DateRoundAmount
Jan 2026Series A
Setsurotech raised 320 million yen in a Series A5 round from Nikon-SBI Innovation Fund II and five other investors.
$2.1M

Investors

Tap an investor to see what else they have backed.

Other companies in Biotech

Other companies in JP

Other companies at Series A stage

Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.